Invesco QQQ (NASDAQ:QQQ) Hits New 1-Year High - Should You Buy?

Invesco QQQ (NASDAQ:QQQ) Hits New 52-Week High - What's Next...

Energy Stocks To Follow Today - April 21st

Tesla, Bloom Energy, AltC Acquisition, ExxonMobil, and GE Vernova are the five Energy stocks to watch today, according to MarketBeat's stock screener tool. Energy stocks are shares of companies...

Tim Cook's Exit, Warsh Faces Congress  Open Interest 4/21/2026

Get a jump start on the US trading day with Matt Miller and Dani Burger on 'Bloomberg Open Interest.' Apple's era shifts as Tim Cook steps down after 15 years, with John Ternus set to take over. And...

Federal Reserve Chair nominee Kevin Warsh said on Tuesday that cryptocurrencies are already embedded in the U.S. financial system, pushing back on the idea that the sector still sits outside mainstream finance.During his Senate confirmation hearing, Warsh was responding to a question from Senator Cynthia Lummis (R-Wyo.), a prominent advocate for digital assets, on whether cryptocurrencies should be integrated into the financial system to expand investment access and consumer protections.<blockquote>“Digital assets are already part of the fabric of our financial-services industry.” – Kevin Warsh, Federal Reserve Chair Nominee.</blockquote><h2 class="st-heading-2">Warsh Rejects CBDC, Calls It ‘Bad Policy Choice’</h2>Warsh also addressed concerns around a potential central bank digital currency. In response to Senator Bernie Moreno (R-OH), he said he would not move the Federal Reserve toward issuing a CBDC if confirmed. Warsh added that such a move would fall within his authority as chair, but emphasized that he believes the Fed does not have the right to issue one and it would be a “bad policy choice.”Financial&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/kevin-warsh-could-be-the-first-fed-chair-with-crypto-exposure/cZBIkO9RICC">disclosures show</a> Warsh holds stakes in more than a dozen crypto firms and trading platforms.<a href="https://stocktwits.com/coins/bitcoin">Bitcoin’s price</a> rose 0.8% over the last 24 hours, attempting to hold above $76,000, while the equities market was in a downswing. The&nbsp;<a href="http://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF Trust (SPY)</a> edged 0.4% lower in midday trade, while the&nbsp;<a href="http://stocktwits.com/symbol/QQQ">Invesco QQQ Trust Series I (QQQ)</a> tumbled 0.2%. On Stocktwits, retail sentiment around the apex cryptocurrency trended in ‘bullish’ territory over the past day, while chatter dipped to ‘normal’ from ‘high’ levels.&nbsp;If confirmed, Warsh would become the first Federal Reserve Chair with venture capital exposure to the cryptocurrency sector. On Kalshi, bettors put a 24% pprobability of him being confirmed before May 15, the day that Jerome Powell’s term expires. Senator Thom Tillis (R-NC)&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/kevin-warsh-could-be-the-first-fed-chair-with-crypto-exposure/cZBIkO9RICC">reportedly</a> vowed to block any Fed nominee until the Justice Department drops its criminal investigation into Powell, which the senator has described as a politically motivated attack on the central bank's independence.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/poet-cfo-calls-short-sellers-maggots-dismisses-wolfpack-tax-day-fears/cZBIifdRICV">EXCLUSIVE: POET CFO Hits Back At Wolfpack Report, Calls Short Sellers ‘Maggots’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Kevin Warsh, U.S. President Donald Trump's nominee for Chair of the Federal Reserve, testifies during his confirmation hearing in the Dirksen Senate Office Building on April 21, 2026 in Washington, DC. (Photo by Andrew Harnik/Getty Images)

Kevin Warsh Says Crypto Already Part Of US Financial System – Calls CBDC A ‘Bad Policy Choice’

Kevin Warsh’s response came in response to Senator Cynthia Lummis’ question on whether or not the Fed nominee thought crypto assets should be a part of the U.S. financial system. 

Cryptocurrency

ImmunityBio, Inc. (IBRX) Class Action Lawsuit Seeks Recovery for Investors; May 26, 2026, Deadline - Contact Kessler Topaz Meltzer & Check, LLP

ImmunityBio, Inc. (IBRX) Class Action Lawsuit Seeks Recovery for Investors; May 26, 2026, Deadline - Contact Kessler Topaz Meltzer & Check, LLP ImmunityBio, Inc. (IBRX) Class Action Lawsuit Seeks...

Avis Brings Back The Short Squeeze  Navitas, Beyond Meat Join In

The Avis Budget short squeeze appears to be spreading to other stocks like Beyond Meat, Opendoor and Lucid.read more...

Webull (NASDAQ:BULL) Shares Gap Up   - Here's Why

Webull (NASDAQ:BULL) Shares Gap Up - Should You Buy...

BlackBerry Limited (BB) Soars to 52-Week High, Time to Cash Out?

BlackBerry (BB) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

<ul class="summary-bullets"><li>Dagco added 451,240 shares, making Sellas its second-largest holding at 1.01% of portfolio weight.</li><li>The stake increase comes ahead of AACR presentation of preclinical data on SLS009, Sellas’ CDK9 inhibitor targeting acute myeloid leukemia (AML).</li><li>Investor focus remains centered on the Phase 3 Regal trial of GPS, with 72 of 80 required survival events recorded as of Dec. 26, moving the study closer to topline analysis.</li></ul>Shares of Sellas Life Sciences Group, Inc. (SLS) jumped 5% in premarket trading on Monday after U.S. investment manager Dagco increased its stake by 78% ahead of a major AACR leukemia data catalyst and the closely watched Regal survival trigger.<a href="https://stocktwits.com/symbol/SLS">SLS stock</a> snapped four sessions of gains on Monday to end over 4% lower at $4.99.<h2 class="st-heading-2">Dagco Loads Up Ahead Of SLS009 AACR Data</h2>Data compiled by Quiver Quantitative showed that Dagco added 451,240 shares on Tuesday, bringing its total holdings to 1.03 million shares valued at $4.35 million as of March 31. The position now represents its second biggest holding at 1.01% of Dagco’s disclosed portfolio, placing Sellas among its healthcare bets alongside larger pharma holdings such as Merck, Thermo Fisher Scientific and Johnson &amp; Johnson.The stake increase comes just as Sellas prepares to present new preclinical findings on SLS009, its CDK9 inhibitor for acute myeloid leukemia (AML), during a poster session at AACR in San Diego on Tuesday.According to the company, lab studies showed that SLS009 triggered leukemia-cell death by increasing activity of caspase-3, a protein involved in the body’s natural cell-death process, while lowering survival signals such as MCL-1 and survivin that help cancer cells persist. The drug also showed stronger potency with repeated exposure, with early biological effects appearing within hours and becoming more pronounced over 24 hours.Notably, SLS009 remained active in AML carrying ASXL1 and TP53 mutations, which are genetic subtypes associated with treatment resistance and poorer outcomes.&nbsp;<h2 class="st-heading-2">Regal Survival Countdown In Focus</h2>While the AACR presentation represents a near-term catalyst, investor attention remains firmly centered on the company’s ongoing Phase 3 Regal trial evaluating GPS, an immunotherapy targeting the Wilms Tumor-1 antigen, as a maintenance treatment for AML patients whose disease returned but later entered remission after additional therapy.The event-driven study will begin final analysis once 80 overall-survival events are recorded. Sellas previously said 72 events had been logged as of Dec. 26, bringing the trial closer to the threshold required to initiate topline analysis.CEO Angelos Stergiou previously said that slower accumulation of survival events in oncology trials can sometimes indicate patients are living longer than expected compared with historical assumptions. Once the 80th event occurs, the company plans to proceed with database lock, statistical analysis, trial unblinding and disclosure of topline results.<h2 class="st-heading-2">How Do Retail Traders Feel About SLS?</h2>On Stocktwits, retail sentiment for SLS was ‘extremely bullish’ amid ‘extremely high’ message volume.<figure class="image"><img src="https://news.stocktwits-cdn.com/sls_ss_png_226ba9d4c9.webp" alt="sls ss.png" width="973" height="147"><figcaption>SLS sentiment and message volume as of April 21 | Source: Stocktwits</figcaption></figure>One user&nbsp;<a href="https://stocktwits.com/yG19/message/650823713">noted</a> Diagco’s stake and said, “It's likely clearly see the asymmetric upside with the margin of safety of no REGAL downside.”<stembedurl>https://stocktwits.com/yG19/message/650823713</stembedurl>Another user&nbsp;<a href="https://stocktwits.com/vlucky16/message/650846855">said</a>, “Can't wait to get update on 009, since GPS has been put on hold for an 80th event that might happen from old age.”<stembedurl>https://stocktwits.com/vlucky16/message/650846855</stembedurl>SLS stock has surged over 280% over the past year.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tesla-stock-premarket-ross-gerber-brand-backlash-ai-pivot-earnings-check/cZBIOqKRICO">Tesla Stock Rises Premarket: Investor Ross Gerber Says ‘People Just Hate The Brand Now’ As AI Pivot Faces Earnings Reality Check</a>

SLS Stock Jumps Premarket: US Investor Dagco Boosts Stake By 78% Ahead Of Fresh Cancer Drug Data Reveal 

Sellas is now Dagco’s second-largest disclosed holding, putting the small-cap leukemia biotech alongside pharma giants like Merck and Johnson & Johnson.

Equity

Social Media Stocks To Follow Today - April 20th

Strive, JOYY, and Trump Media & Technology Group are the three Social Media stocks to watch today, according to MarketBeat's stock screener tool. Social media stocks are shares of publicly traded...

SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is seeing intense volatility driven by a technical short squeeze and heavy concentration of ownership, prompting heated debates among traders over whether the surge is a sustainable momentum play or a manipulated trap. The community is actively tracking institutional filings and options flow while warning of the high-risk, exit-liquidity nature of the current price action.

Beyond Meat, Inc. engages in the provision of plant-based meats. Its products include ready-to-cook meat under The Beyond Burger and Beyond Sausage brands, and frozen meat, namely, Beyond Chicken Strips and Beyond Beef Crumbles. The company was founded by Ethan Walden Brown and Brent Taylor in 2009 and is headquartered in El Segundo, CA.

Beyond Meat Inc

Beyond Meat is driving intense community debate as traders weigh the potential for a massive short squeeze against significant long-term dilution and weak business fundamentals. While the stock's elevated borrow rates and heavy volume have ignited speculation of a parabolic move, many participants remain wary, viewing the surge as a high-risk speculative play driven by retail momentum and intense battle between bulls and bears.

Battalion Oil Corp. is an independent energy company, which engages in the acquisition, production, exploration, and development of onshore liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil is experiencing significant volatility as investors weigh the potential for a regional energy crisis against ongoing uncertainty surrounding the geopolitical situation in the Middle East. The community is actively debating the impact of potential supply disruptions, dilution concerns, and the credibility of diplomatic headlines while monitoring for a breakout from the stock's current consolidation phase.

Faraday Future Intelligent Electric, Inc. is an emerging growth company, which manufactures electric vehicles. The company was founded by Jia Yueting in May 2014 and is headquartered in Gardena, CA.

Faraday Future Intelligent Electric Inc - Ordinary Shares - Class A

Faraday Future Intelligent Electric Inc

Faraday Future is seeing high retail engagement driven by recent news of a financing agreement and an expansion into embodied AI robotics education, sparking intense debate between traders anticipating a momentum-driven squeeze and skeptics focused on the company's history of dilution and potential reverse stock split.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as investors react to a significant expansion of its partnership with NVIDIA, which integrates QNX technology into AI-driven robotics and industrial systems. The community is actively debating the stock's transition from a legacy brand to a critical infrastructure provider, fueled by high volume and bullish sentiment surrounding its growing role in physical AI.

CytoDyn, Inc. is a clinical-stage biotechnology company, which focuses on the clinical development of innovative treatments for multiple therapeutic indications based on its product candidate, leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5. Its pipeline includes Leronlimab Clinical Development Pipeline and Long-Acting CCR5 Inhibitor Development Pipeline. The company was founded by Allen D. Allen on May 2, 2002 and is headquartered in Vancouver, WA.

Cytodyn Inc

CytoDyn Inc

CytoDyn is trending as investors gear up for the American Association for Cancer Research (AACR) annual meeting, where the community is focused on upcoming poster presentations for the leronlimab mTNBC and mCRC trials. Bullish sentiment is being driven by anticipation of new clinical data and recent buzz around the potential for leronlimab to serve as a 'universal primer' that enhances the efficacy of existing immunotherapy treatments.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is seeing significant investor interest driven by a combination of positive housing market data, institutional accumulation, and anticipation of upcoming earnings reports. The community is actively debating the stock's potential for a short squeeze, fueled by high short interest and enthusiasm for the company's strategic shift toward vertical integration of mortgage and title services.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is trending as investors aggressively discuss persistent rumors of a potential buyout, fueled by recent hiring activity and comparisons to successful acquisitions within the biotech sector. The community is actively debating the stock's price action and institutional accumulation, with many expressing frustration over the lack of official news despite strong long-term growth prospects.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is trending as the community debates potential AI data center partnerships and leadership changes, with many traders closely watching for a breakout amid heavy call option activity and persistent short interest. While bulls highlight the company's power-efficient GaN technology and institutional accumulation, bears remain skeptical, focusing on valuation concerns and recent insider selling activity.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is currently navigating intense market volatility driven by its high correlation to Bitcoin's price fluctuations and ongoing speculation surrounding the pending Clarity Act. While some investors are concerned about potential legislative delays and weak price action relative to broader crypto trends, others view the stock as a long-term infrastructure play, pointing to institutional growth and the increasing utility of the company's exchange platform.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


News